Company GelStat Corp. Other OTC

GSAC

US3685331056

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

GelStat Corporation is engaged in research, development, marketing and branding of advanced technology operations. The Company's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security. The Company has acquired the intellectual property of Duos Technologies Group, Inc.

USD in Million	2022	Weight	2023	Weight	Delta
Consumer Healthcare Products 100.0 %	0	100.0 %	0	100.0 %	+6,309.22%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	+6,309.22%

Managers	Title	Age	Since
Javier G. Acosta CEO	Chief Executive Officer	-	-

Members of the board	Title	Age	Since
William R. Colucci BRD	Director/Board Member	85	27/07/27
Adrian Goldfarb CHM	Chairman	66	01/08/01
Paul W. Bucha BRD	Director/Board Member	81	04/11/04
Javier G. Acosta CEO	Chief Executive Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	524,993,540	679,317,507 ( 129.40 %)	0	129.40 %

Name	Equities	%	Valuation
Dinamik SA 0.0243 %	150,000	0.0243 %	- $

GelStat Corp.

7554 SW Jack James Drive

34997, Stuart

http://www.gelstat.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
NOVO NORDISK A/S	+31.37%	60TCr
JOHNSON & JOHNSON	-2.60%	37TCr
MERCK & CO., INC.	+20.83%	33TCr
ABBVIE INC.	+5.69%	29TCr
ASTRAZENECA PLC	+14.83%	24TCr
NOVARTIS AG	+9.93%	21TCr
ROCHE HOLDING AG	-6.95%	20TCr
AMGEN INC.	+10.77%	17TCr
PFIZER, INC.	+0.10%	16TCr

Other Pharmaceuticals